109 related articles for article (PubMed ID: 6874578)
21. A possible translational control of 3-hydroxy-3-methylglutaryl coenzyme A reductase induction by ML-236b(compactin) in isolated rat hepatocytes.
Koizumi J; Mabuchi H; Takeda R; Okamoto H
Biochem Biophys Res Commun; 1982 Sep; 108(1):240-6. PubMed ID: 7150285
[No Abstract] [Full Text] [Related]
22. Therapeutic effects of ML-236B in primary hypercholesterolemia.
Yamamoto A; Sudo H; Endo A
Atherosclerosis; 1980 Mar; 35(3):259-66. PubMed ID: 7362699
[TBL] [Abstract][Full Text] [Related]
23. A two component-type cytochrome P-450 monooxygenase system in a prokaryote that catalyzes hydroxylation of ML-236B to pravastatin, a tissue-selective inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase.
Serizawa N; Matsuoka T
Biochim Biophys Acta; 1991 Jun; 1084(1):35-40. PubMed ID: 1905157
[TBL] [Abstract][Full Text] [Related]
24. Overaccumulation of 3-hydroxy-3-methylglutaryl-coenzyme-A reductase in a compactin(ML-236B)-resistant mouse cell line with defects in the regulation of its activity.
Hasumi K; Yamada A; Shimizu Y; Endo A
Eur J Biochem; 1987 May; 164(3):547-52. PubMed ID: 3569277
[TBL] [Abstract][Full Text] [Related]
25. Reduction of serum cholesterol in heterozygous patients with familial hypercholesterolemia. Additive effects of compactin and cholestyramine.
Mabuchi H; Sakai T; Sakai Y; Yoshimura A; Watanabe A; Wakasugi T; Koizumi J; Takeda R
N Engl J Med; 1983 Mar; 308(11):609-13. PubMed ID: 6828091
[TBL] [Abstract][Full Text] [Related]
26. Effect of increased dosage of the ML-236B (compactin) biosynthetic gene cluster on ML-236B production in Penicillium citrinum.
Abe Y; Suzuki T; Mizuno T; Ono C; Iwamoto K; Hosobuchi M; Yoshikawa H
Mol Genet Genomics; 2002 Sep; 268(1):130-7. PubMed ID: 12242508
[TBL] [Abstract][Full Text] [Related]
27. A quantitative analysis of nuclear magnetic relaxation: the configuration and the conformation of ML-236B (mevastatin) metabolites.
Haruyama H; Kondo M
Chem Pharm Bull (Tokyo); 1987 Jan; 35(1):170-81. PubMed ID: 3594648
[No Abstract] [Full Text] [Related]
28. Isolation of compactin (a hypocholestrolemic metabolite) from a new source: Penicillium cyclopium.
Doss SL; Chu CK; Mesbah MK; Cutler HG; Cole PD; Arrendale RF; Springer JP
J Nat Prod; 1986; 49(2):357-8. PubMed ID: 3734817
[No Abstract] [Full Text] [Related]
29. Competitive inhibition of 3-hydroxy-3-methylglutaryl coenzyme A reductase by ML-236A and ML-236B fungal metabolites, having hypocholesterolemic activity. 1976.
Endo A; Kuroda M; Tanzawa K
Atheroscler Suppl; 2004 Oct; 5(3):39-42. PubMed ID: 15531273
[No Abstract] [Full Text] [Related]
30. Combined drug therapy--cholestyramine and compactin--for familial hypercholesterolemia.
Yamamoto A; Yamamura T; Yokoyama S; Sudo H; Matsuzawa Y
Int J Clin Pharmacol Ther Toxicol; 1984 Sep; 22(9):493-7. PubMed ID: 6500769
[TBL] [Abstract][Full Text] [Related]
31. Improvement of compactin (ML-236B) production by genetic engineering in compactin high-producing Penicillium citrinum.
Baba S; Abe Y; Suzuki T; Ono C; Iwamoto K; Nihira T; Hosobuchi M
Appl Microbiol Biotechnol; 2009 Jun; 83(4):697-704. PubMed ID: 19277641
[TBL] [Abstract][Full Text] [Related]
32. Competitive inhibition of 3-hydroxy-3-methylglutaryl coenzyme A reductase by ML-236A and ML-236B fungal metabolites, having hypocholesterolemic activity.
Endo A; Kuroda M; Tanzawa K
FEBS Lett; 1976 Dec; 72(2):323-6. PubMed ID: 16386050
[No Abstract] [Full Text] [Related]
33. The effect of compactin, a potent inhibitor of 3-hydroxy-3-methylglutaryl coenzyme-A reductase activity, on cholesterogenesis and serum cholesterol levels in rats and chicks.
Fears R; Richards DH; Ferres H
Atherosclerosis; 1980 Apr; 35(4):439-49. PubMed ID: 7189661
[TBL] [Abstract][Full Text] [Related]
34. Biosynthesis of monacolins: conversion of monacolin J to monacolin K (mevinolin).
Kimura K; Komagata D; Murakawa S; Endo A
J Antibiot (Tokyo); 1990 Dec; 43(12):1621-2. PubMed ID: 2276983
[No Abstract] [Full Text] [Related]
35. Compactin-a review.
Chakravarti R; Sahai V
Appl Microbiol Biotechnol; 2004 Jun; 64(5):618-24. PubMed ID: 15034683
[TBL] [Abstract][Full Text] [Related]
36. Growth inhibition of yeast by compactin (ML-236B) analogues.
Ikeura R; Murakawa S; Endo A
J Antibiot (Tokyo); 1988 Aug; 41(8):1148-50. PubMed ID: 3170348
[No Abstract] [Full Text] [Related]
37. Functional analysis of mlcR, a regulatory gene for ML-236B (compactin) biosynthesis in Penicillium citrinum.
Abe Y; Ono C; Hosobuchi M; Yoshikawa H
Mol Genet Genomics; 2002 Nov; 268(3):352-61. PubMed ID: 12436257
[TBL] [Abstract][Full Text] [Related]
38. The synthesis of compactin (ML-236B) and monacolin K in fungi.
Endo A; Hasumi K; Yamada A; Shimoda R; Takeshima H
J Antibiot (Tokyo); 1986 Nov; 39(11):1609-10. PubMed ID: 3793631
[No Abstract] [Full Text] [Related]
39. Enantioselective synthesis of cyclohexenone derivatives by a chemicoenzymatic approach: stereo- and regioselective route to potential intermediates of compactin (ML 236B) and mevinolin.
Kobayashi S; Eguchi Y; Shimada M; Ohno M
Chem Pharm Bull (Tokyo); 1990 Jun; 38(6):1479-84. PubMed ID: 2208366
[TBL] [Abstract][Full Text] [Related]
40. Acetoacetyl-CoA synthetase specific activity and concentration in rat tissues.
Ito M; Fukui T; Saito T; Tomita K
Biochim Biophys Acta; 1986 Apr; 876(2):280-7. PubMed ID: 3082367
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
